|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | A61K 45/06 | |
| A61P 11/00 | |||
| A61K 47/10 | |||
| A61K 9/00 | |||
| A61K 47/32 | |||
| A61P 11/02 | |||
| A61K 31/56 | |||
| A61K 31/58 | |||
| A61K 47/24 | |||
| A61K 47/26 | |||
| A61K 47/34 | |||
| A61K 47/44 |
| (11) | Patento numeris | 1471884 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 03702727.3 |
| Europos patento paraiškos padavimo data | 2003-02-04 | |
| (97) | Europos patento paraiškos paskelbimo data | 2004-11-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-10-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/GB2003/000469 |
| Data | 2003-02-04 |
| (87) | Numeris | WO 2003/066026 |
| Data | 2003-08-14 |
| (30) | Numeris | Data | Šalis |
| 66951 | 2002-02-04 | US |
| (72) |
BIGGADIKE, Keith, GlaxoSmithKline, GB
BUXTON, Ian, GlaxoSmithKline Inc., CA
DALEY-YATES, Peter, Terence, GlaxoSmithKline, GB
FONG, Bettina, GlaxoSmithKline Inc., CA
HO, Elita, Y., GlaxoSmithKline Inc., CA
REED, Kenton, Lewis, GlaxoSmithKline Inc., CA
SAYANI, Amyn, GlaxoSmithKline Inc., CA
|
| (73) |
Glaxo Group Limited,
980 Great West Road, Brentford, Middlesex TW8 9GS,
GB
|
| (54) | PHARMACEUTICAL FORMULATION COMPRISING AN ANDROSTANE DERIVATIVE AND A SOLUBILISING AGENT IN AN AQUEOUS LIQUID CARRIER |
| PHARMACEUTICAL FORMULATION COMPRISING AN ANDROSTANE DERIVATIVE AND A SOLUBILISING AGENT IN AN AQUEOUS LIQUID CARRIER |